Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
and More Upticks and BUYS AT THE ASK! $.07s getting hit right now. $NFRX strong early on and 8-10 cents could come quickly
The demand for predictive analytics technology has increased dramatically in the last several years in industries such as financial services, healthcare, and the Government. In today's global business environment, staying ahead of the competition is a pre-requisite for long-term growth and in a tough economy — survival. The latest trend in business intelligence is to leverage corporate data assets from customers, competitors, partners, suppliers, and supply chains. Moreover, in the Government market, the need for advanced predictive analytics to analyze data in multiple remote locations has significantly increased due to heightened worldwide security concerns and the proliferation of databases across the intelligence community and federal agencies.
Capitalizing on the information embedded in the data a company owns about its customers, partners, and suppliers is critical for sustainable growth in information rich business environments. However, building an infrastructure which can take advantage of the majority of a company's distributed assets in detecting opportunities and risks is time consuming and a costly proposition. The global enterprise needs to have the flexibility to make decisions in real-time while being able to access the data from multiple enterprise systems to deal with complex and fluctuating patterns.
InferX $NFRX technology provides its financial services, healthcare, and government clients with a unique IT platform to deal with enterprise wide databases with both structured and unstructured data while managing new business opportunities and risks without the need for to integrate the data. The information may reside in different systems and even in different locations of the global enterprise. This offers an unprecedented opportunity to an enterprise to achieve high and immediate return on investment.
Products Highlights for $NFRX -
INFERX'S PREDICTIVE ANALYTICS PRODUCTS are getting attention in 2013 -
Distributed Data Analytics Platform
InferAgent
InferText
InferCluster
Professional Services
INFERX PRODUCTS OFFER THE FOLLOWING ADVANTAGES:
>Empowers data owners with total control
>Provides near real-time analysis and predictions
>Keeps the data concealed by encrypting the results
>Eliminates the need for creating data warehouses
>Works with multiple databases in different formats
>Predicts future risks and opportunities over networks
>Accesses and mines structured and unstructured data remotely
>Increases speed over conventional methods by employing parallel analysis
NFRX
Looking very good here ! Like green out of the gate for NFRX!!!
NFRX Products REDUCED COSTS
Next generation business intelligent solutions employing InferX distributed predictive analytics system eliminates the need for a data warehouse which typically accounts for 50 to 75 percent of implementation costs, adds 12 to 18 months implementation time, and many additional on-going support and maintenance expenses.
GREEN OUT THE GATE! $NFRX is Making Rounds and getting attention - http://finance.yahoo.com/q?s=nfrx&ql=1
InferX is the market leader in next generation distributed Predictive Analytics and Business Intelligence Products and Solutions. InferX has pioneered and commercialized a powerful, patented suite of advanced data analytical solutions that improve corporate performance across the enterprise in the healthcare, financial services, and government markets. InferX is uniquely capable of delivering secure, real-time, and privacy preserving intelligence and decision support — all without the need to move data. InferX is headquartered in Tysons Corner, VA. For more information go to the InferX website www.inferx.com
NFRX Products INCREASED BENEFITS
Real-time analysis and results improve decision support and access to additional data sources beyond those in a data warehouse and provides better input and more context for analysis. Benefits will typically include increased revenues, lower costs and improved strategic position.
InferX products are revolutionizing the next generation business intelligence and predictive analytics marketplace for several reasons:
NFRX
Sounds good imo. Seems like it has the right sectors to be in these days as well!
How does the $NFRX L2 look right now? Are we churning already???
starting up 20% this morning! >>
http://www.inferx.com/news.htm
$NFRX Website: http://www.inferx.com
$NFRX News: http://finance.yahoo.com/q/h?s=NFRX+Headlines
$NFRX Live Chart: http://stockcharts.com/c-sc/sc?s=NFRX&p=D&b=5&g=0&i=p56255651791&r=1369137857604
Yes 2012 was a news hot year for $NFRX and some newer traders have forgotten or know Not of the NEws back then......
The NFRX news links have historical significance here >>
http://www.inferx.com/news.htm
HIRES and MGMT Are what make SUCCESSFUL SMall Cap Stocks - $NFRX is putting itself in position for success.
In addition to powerful threat and risk assessment capabilities, InferX solutions provide a number of valuable ancillary benefits such as the delivery of meaningful real-time business intelligence that can be leveraged to optimize opportunities, mitigate economic risks and promote operational excellence across the enterprise.
NFRX
NFRX InferX software solutions use 'collective inferencing' where seemingly meaningless data becomes important by identifying unusual or suspicious events, conditions and sequences that may occur in the movement of people, products, services or information. With InferX solutions, there is no need to move data; instead only knowledge moves in the form of encryption pointers ensuring security and privacy. The products access, analyze and perform predictive analyses in real-time on multiple, distributed, and disparate databases and on reports, e-mails and other text-based documents.
NFRX Products Overview
InferX offers a wide range of next generation predictive analytics and business intelligence solutions that are designed to help a wide range of enterprise and government entities improve their business performance and service to their customer. Employing proprietary "knowledge agents" to remotely analyze large scale data sources, InferX products seamlessly analyze both structured and unstructured data sources plus have many features that offer users a tremendous return on investment.
http://www.inferx.com/products.htm
uhhhhhh the SS in the IBOX NEEDS UPDATING For $NFRX Shareholders haha - Last verified by mkt_predictor on 4/15/2009 with transfer agent, and O/S has not changed since late December 2008.
Authorized Shares (AS) = 75,000,000
Outstanding Shares (OS) = 17,738,510
http://finance.yahoo.com/q/ks?s=IFRX.OB
Float Derivation: Since the OS for IFRX is 13.69M within that Yahoo link above, that leaves a difference of 4.04M from the 17.73M shares verified as the OS by mkt_predictor from the Transfer Agent (TA) on 02 April 2009. For this reason, I think the true float is currently the 6.59 number reflected within that Yahoo link above plus the 4.04M OS difference as a worst case scenario total float shares of 10.63M shares.
NFRX Contact:
InferX Corporation
Tel 703-444-6030
Fax 703-444 2119
www.inferx.com
Investor Relations:
SmallCapVoice.com
Stuart T. Smith
512-267-2430
info@smallcapvoice.com
About InferX Corporation
InferX is the market leader in next generation distributed Predictive Analytics and Business Intelligence Products and Solutions. InferX has pioneered and commercialized a powerful, patented suite of advanced data analytical solutions that improve corporate performance across the enterprise in the healthcare, financial services, and government markets. InferX is uniquely capable of delivering secure, real-time, and privacy preserving intelligence and decision support — all without the need to move data. InferX is headquartered in Sterling, VA.
For more information go to the InferX website www.inferx.com.
NFRX
NFRX InferX Corporation Expands Management Advisory Board; Two New Members Appointed
Read Complete: http://finance.yahoo.com/news/inferx-corporation-expands-management-advisory-164435757.html
STERLING, Va., March 21, 2013 (GLOBE NEWSWIRE) -- InferX Corporation (NFRX) announced today appointment of two new members to the InferX Management Advisory Board.
Lawrence Hoffman is a Senior Partner at Raffa P.C., a regional accounting firm based in Washington, D.C., and brings strong qualifications in the financial sector, with particular strengths in the area of forensic accounting and fraud/risk assessment. Building on InferX's prior work with a "Big Four" accounting firm identifying suspect transactions, we are working with Mr. Hoffman to explore creating an analysis practice area to support new CA/CM capabilities ('Continuous Auditing/Continuous Monitoring') which we believe is a high priority among major corporations.
Oliver Alabaster, M.D. is an Oncologist and was a Professor at the GWU Medical Center in Washington, D.C. where he was Director of Cancer Research for twenty years and also the Director of the Institute for Disease Prevention. Dr. Alabaster helped to found the Prevent Cancer Foundation in 1986 and was formerly Vice-Chairman of the Board. He has agreed to assist InferX in developing a predictive analytics solution to identify patients with a high risk of cancer. The proposed solution would be similar to the analytics framework used by InferX to successfully develop the Acute Kidney Injury ("AKI") proof of concept in cooperation with leading researchers in Nephrology at the GWU Medical Center.
The new appointments further complement the Company's existing Management Advisory Board and additional appointments are expected.
InferX pioneered and commercialized a powerful, proprietary suite of predictive data analysis technologies and tools. The Company has two patents issued for its real time, distributed predictive analytics and business intelligence system.
"Developing innovative new solutions to improve performance, reduce costs, increase revenues and even help save lives- that is how next generation analytics is driving today's today's IT revolution, said Paul B. Silverman, InferX CEO and President. "We are changing traditional rules of market, strategy,and operations analysis, driving economic growth, and creating exciting new opportunities. I am pleased Lawrence Hoffman and Dr. Alabaster have joined the InferX team and welcome their support helping InferX meet its ambitious growth objectives in the financial services and healthcare sectors," said Silverman.
Market opening any second now. This FLOAT and NEWS make me think we have a shot at a great run out of the gate. That would open some eyes and bring back some $NFRX Traders!
NFRX in the NEWS
Tuesday, May 21, 2013
InferX Corporation Expands Management Advisory Board; New Member AppointedPR Newswire(Tue 8:00AM EDT)
Thursday, March 21, 2013
InferX Corporation Expands Management Advisory Board; Two New Members AppointedGlobeNewswire (Thu, Mar 21)
December 27, 2012
InferX Corporation Executive Management Team Expanded; Paul B. Silverman Joins as CEO and President; Carl Eckstein Joins Boar...
April 16, 2012
InferX Corporation Patented Predictive Analytics Technology Selected by Agency of Department of Treasury
9/07/11
InferX Corporation Awarded $1,000,000 in Department of Defense Contracts
8/17/11
IInferX Corporation Appoints Ben Chou, Sales Director
08/15/11
InferX Corp Announces Financial Results for Second Quarter of Fiscal Year 2011
"Developing innovative new solutions to improve performance, reduce costs, increase revenues and even help save lives- that is how next generation analytics is driving today's today's IT revolution, said Paul B. Silverman, InferX CEO and President. "We are changing traditional rules of market, strategy,and operations analysis, driving economic growth, and creating exciting new opportunities. I am pleased Lawrence Hoffman and Dr. Alabaster have joined the InferX team and welcome their support helping InferX meet its ambitious growth objectives in the financial services and healthcare sectors," said Silverman. $NFRX
NFRX Products Highlights
INFERX'S PREDICTIVE ANALYTICS PRODUCTS
Distributed Data Analytics Platform
InferAgent
InferText
InferCluster
Professional Services
NFRX INFERX IS A MARKET LEADER IN NEXT GENERATION PREDICTIVE ANALYTICS AND BUSINESS INTELLIGENCE PRODUCTS AND SERVICES. INFERX OFFERS A POWERFUL SUITE OF ADVANCED DATA ANALYTICAL PRODUCTS TO IMPROVE PERFORMANCE ACROSS THE ENTERPRISE.
NFRX is adding to their portfolio of strong management!
Oliver Alabaster, M.D. is an Oncologist and was a Professor at the GWU Medical Center in Washington, D.C. where he was Director of Cancer Research for twenty years and also the Director of the Institute for Disease Prevention. Dr. Alabaster helped to found the Prevent Cancer Foundation in 1986 and was formerly Vice-Chairman of the Board. He has agreed to assist InferX in developing a predictive analytics solution to identify patients with a high risk of cancer. The proposed solution would be similar to the analytics framework used by InferX to successfully develop the Acute Kidney Injury ("AKI") proof of concept in cooperation with leading researchers in Nephrology at the GWU Medical Center.
The new appointments further complement the Company's existing Management Advisory Board and additional appointments are expected.
InferX pioneered and commercialized a powerful, proprietary suite of predictive data analysis technologies and tools. The Company has two patents issued for its real time, distributed predictive analytics and business intelligence system. $NFRX
InferX Corporation (NFRX) $NFRX announced today appointment of two new members to the InferX Management Advisory Board.
Lawrence Hoffman is a Senior Partner at Raffa P.C., a regional accounting firm based in Washington, D.C., and brings strong qualifications in the financial sector, with particular strengths in the area of forensic accounting and fraud/risk assessment. Building on InferX's prior work with a "Big Four" accounting firm identifying suspect transactions, we are working with Mr. Hoffman to explore creating an analysis practice area to support new CA/CM capabilities ('Continuous Auditing/Continuous Monitoring') which we believe is a high priority among major corporations.
InferX Corporation $NFRX Expands Management Advisory Board; Two New Members Appointed
http://finance.yahoo.com/news/inferx-corporation-expands-management-advisory-164435757.html
Not the purtiest site ever but does navigate well, with loads of NFRX information!
Quite a summary for NFRX!
NFRX Business Summary
InferX Corporation provides predictive analytics and business intelligence solutions for the healthcare, financial services, and government markets worldwide. Its solutions include technologies that provide results for challenges, such as healthcare fraud mitigation, financial services risk management, and complex intelligence analysis. The companys patented and patent-pending products simultaneously analyze data in multiple remote locations with disparate formats without the need to move the data to a central data warehouse. Its predictive analytics enterprise software products include InferAgent, which offers the user with the power to access, analyze, and perform predictive analytics on structured data from distributed relational database management system; InferText that provides the customer with the power to access, analyze, and perform predictive analytics on unstructured data, including emails, blogs, written forms, etc.; and InferCluster, a component of its distributed data analytics platform designed to assign sets of observations into subsets. The company also offers business intelligence and corporate performance consulting services in the public sector, as well as private sector and financial services clients. Its business intelligence services comprise receivables and payables analysis, customer profitability, product profitability, regulatory compliance, expense management, and cash flow analysis. InferX Corporation was founded in 1992 and is based in Sterling, Virginia.
Insider Carl Eckstein (Director) holds and bought 500K shares of NFRX on Dec 26, 2012
Looks like they have some industry pro's on board this ship here!
You know what that means...more PRs to come for NFRX, or why would they hire a guy with Fortune 50 experience!?
Yes, I noticed that as well...NFRX 0.04 is critical support.
"Developing innovative new solutions to improve performance, reduce costs, increase revenues and even help save lives- that is how next generation analytics is driving today's IT revolution." said Paul B. Silverman, InferX $NFRX CEO and President. "We are changing traditional rules of market, strategy, and operations analysis, driving economic growth, and creating exciting new opportunities. Bob King brings excellent experience and I am pleased he has agreed to join the InferX team and welcome his support," said Silverman.
Bet NFRX moves on air if we see 500k in volume!
InferX pioneered and commercialized a powerful, proprietary suite of predictive data analysis technologies and tools. InferX has two patents issued for its real time, distributed predictive analytics and business intelligence system. $NFRX
Mr. King brings extensive knowledge of social media and open source in the Intelligence community, with a demonstrated track record of success at both Fortune 50 companies and start-up environments. Mr. King has worked with a wide range of leading companies including Motorola, SAIC, Vulcan Inc, General Instrument, Magis Networks, Claria and Prodyx, Inc. Mr. King will assist InferX in developing several targeted predictive analytics solutions for its planned new Global Analytics Cloud family of internet-based services.
The new appointment further complements InferX's existing Management Advisory Board. InferX expects to make additional appointments to its Board of Advisors in the near future. $NFRX
InferX Corporation (OTC/PK:NFRX) $NFRX is pleased to announce the appointment of Robert M. King as a new member of the InferX Management Advisory Board. Mr. King is a skilled senior executive in creating new revenue- producing lines of business as well as delivering products. Mr. King brings significant experience in Cybersecurity, Big Data Analytics, SaaS including end-to-end systems integration which is a key element within InferX's upcoming rollout of its Release 2.0 predictive analytics product suite.
NFRX $0.04 nice support on the chart, and volxprice is holding that area as support.
NFRX looks pretty interesting here, a nice little floater to be on watch.
NFRX rarely trades, light volume so far, could be seeing a pop in vol over 500K+
InferX Corporation Expands Management Advisory Board; New Member Appointed $NFRX News - http://finance.yahoo.com/news/inferx-corporation-expands-management-advisory-120000595.html
No questions, with the amount of room between the O/S and A/S, plenty of space for adding restricted shares that will go into investment vehicles allowing acquisitions!
Followers
|
18
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2266
|
Created
|
10/09/08
|
Type
|
Free
|
Moderators |
InferX 2.0 (Merger of InferX and The Irus Group)
We announced our intent to merge with The Irus Group to optimize the business and build shareholder value. Since August 2008 we have been working with The Irus Group under an MOU which laid the foundation of working with them as a partner and then specific teaming opportunities in Healthcare and Government sector. The significant synergies and close cooperation between InferX and The Irus Group led to the decision to merge. Irus Group is a top business intelligence and corporate performance management solution provider that works with several major financial services firms and government organizations to turn their data into information and their information into knowledge, which leads to better business decisions. This business objective is similar to the focus of InferX. The Irus Group also has a long history of providing planning and budgeting solutions to financial management at some of the world's largest commercial and government customers which will help InferX 2.0 capitalize on cross selling opportunities for our product suite. The Irus Group's 2008 revenues were approximately $6.0 million, and it is profitable. To comply with SEC rules, its financial statements are being audited by InferX's auditors.
We believe that the clients of the impacted businesses, as well as InferX shareholders, will be in a better position to optimize value as a result of this merger. We will continue to manage our businesses with this principle in mind, and we are focused on delivering results that support InferX 2.0. We made a series of structural changes as we entered in the New Year: integrating our organization structure, bringing new leaders, enhancing capital management, and better aligning our incentive structure to promote sales of products and solutions. We are at a crossroads and making important decisions in 2009 about the company we aspire to be. Altering the mix of businesses that compose InferX was among the most transformational actions taken until now.
As part of InferX 2.0, we adopted a principle that we would only participate in businesses where we either have - or could project - a clear path to a leadership. As a merged entity, we believe we possess those characteristics in our financial businesses; we determined that operating in the Government Sector, Healthcare Sector and Financial Services Sector would allow us to maximize shareholder value. Although our first priority is the integration of The Irus Group, we will continue to consider opportunities to expand our scale and differentiation through acquisition.
Innovation is also a driving force of InferX 2.0. We are grateful to our technical management team and believe that their creativity, innovation and tenacity will produce even greater results in the future. It is our people who continue to make the difference.
As management, we know that our ultimate responsibility is to provide value to clients and strong returns for shareholders. Regardless of near-term share price performance, we are confident that we have taken the actions that should provide attractive returns for our shareholders for many years.
The New InferX
Inside the company we refer to ourselves as "The New InferX" to reflect the many actions we are taking in 2009 and the vast opportunities we believe await us. We have lot of work ahead of us and once the complete integration has taken place and reporting is done for Q2 2009, we will be able to share forward looking pro-forma projections of The New InferX with our shareholders. We have a low capital business model which we believe will deliver attractive earnings, operating margins and cash flow.
We enter 2009 with what we believe will make us the leading provider of next generation business intelligence and predictive analytics solutions for the broad financial services industry. We offer a variety of leading solutions in healthcare fraud, financial services risk management and complex intelligence analysis in the government sector. Our goal is to not only deliver the products that we have today, but to increase integration and innovation so that we can provide even more client value in the future. That is the essence of The New InferX.
We envision The New InferX playing a larger role with increased focus on the end-users of our technology. We are increasing our thought leadership and product innovation to ensure that InferX clients are the beneficiaries of the best technology solutions available.
We believe that our shareholders will benefit from a strong focus on profitable growth during 2009. We are developing a new business model that focuses on recurring revenue and that is based on achieving profitability. We expect to extend our broad operating competencies across an enterprise to enhance the results from licensing our software suite and to generate cash flow that will be managed with the goal of optimizing shareholder value.
B.K.Gogia
Chairman of the Board
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |